FRANK THOMAS Net Worth - Insider Trades and Bio as of Jun 11, 2026

LRMRLarimar Therapeutics, Inc.SEC CIK: 0001242616

Estimated Net Worth

$3.6 Million

Last Updated: May 19, 2026 11:11 PM EST

Transaction Summary

Total Transactions86

Buy-Sell Ratio1.33

Buy Transactions8

Sell Transactions6

Transaction Volume

Total Volume-$2.46M

Net Volume$2.66M

Buy Volume$98.76K

Sell Volume-$2.56M

Trade Analysis

AVG Trade Size-$38.62K

Largest Trade$1.60M

Most Active MonthJun

Most Active Year2020

Trading Sentiment

OverallBullish

Recent TradeBuying

Last 90 Days0 Trades

ConvictionNone

Net Worth & Trading Activity Over Time

Monthly Trading Pattern

Past Insider Trading and Trends

Frank E Thomas has an estimated net worth of $3.6 Million. This is based on reported shares across multiple companies, which include Spero Therapeutics, Inc., Larimar Therapeutics, Inc., AMAG PHARMACEUTICALS INC., Orchard Therapeutics plc, CRITICAL THERAPEUTICS INC, and ESPERION THERAPEUTICS INC/MI.

2022 was Frank E Thomas's most active year for acquiring shares with 14 total transactions. Frank E Thomas's most active month to acquire stocks was the month of January. 2024 was Frank E Thomas's most active year for disposing of shares, totalling 11 transactions. Frank E Thomas's most active month to dispose stocks was the month of December. 2006 saw Frank E Thomas paying a total of $1,618,729.10 for 1,075,885 shares, this is the most they've acquired in one year. In 2004 Frank E Thomas cashed out on 207,778 shares for a total of $1,707,230.00, their largest year based on trade value.

Holdings & Transactions

LRMRlarimar therapeutics, inc.

Updated: Mar 02, 2026VIEW QUOTE

Form Type	Δ Own, %	Traded Shares	Price	Size, $	Filing Date	Own, %	Type	Scheduled	Trade Dates	SEC Filing
From 4	2.50	5.00K	$5.00	$25.00K	Mar 02, 2026	7.00K	Purchase	—	Feb 27	View
From 4	—	19.00K	—	—	May 14, 2025	19.00K	Grant	—	May 13	View
From 4	—	19.00K	—	—	May 31, 2024	19.00K	Grant	—	May 29	View
From 4	—	2.00K	$11.00	$22.00K	Feb 15, 2024	2.00K	Purchase	—	Feb 14	View
From 4	—	8.30K	—	—	May 11, 2023	8.30K	Grant	—	May 09	View
From 4	—	8.30K	—	—	May 12, 2022	8.30K	Grant	—	May 10	View
From 4	—	8.30K	—	—	May 17, 2021	8.30K	Grant	—	May 12	View
From 4	—	16.60K	—	—	Sep 30, 2020	16.60K	Grant	—	Sep 29	View
From 4	—	27.00K	—	—	Jun 27, 2019	27.00K	Grant	—	Jun 26	View
From 4	—	20.00K	—	—	Jun 07, 2018	20.00K	Grant	—	Jun 06	View
From 4	—	14.50K	—	—	Jun 23, 2017	14.50K	Grant	—	Jun 21	View
From 4	—	12.00K	—	—	Jul 01, 2016	12.00K	Grant	—	Jun 30	View
From 4	—	12.00K	—	—	Jul 15, 2015	12.00K	Grant	—	Jul 13	View
From 4	—	13.33K	—	—	Jun 26, 2014	13.33K	Grant	—	Jun 24	View
From 3	—	—	—	—	Jun 18, 2014	—	—	—	—	View

SPROspero therapeutics, inc.

Updated: Jun 16, 2025VIEW QUOTE

Form Type	Δ Own, %	Traded Shares	Price	Size, $	Filing Date	Own, %	Type	Scheduled	Trade Dates	SEC Filing
From 4	0.36	20.00K	—	—	Jun 16, 2025	75.00K	Grant	—	Jun 12	View
From 4	0.57	20.00K	—	—	May 30, 2024	55.00K	Grant	—	May 29	View
From 4	1.33	20.00K	—	—	Oct 10, 2023	35.00K	Grant	—	Oct 05	View
From 4	—	15.00K	—	—	Sep 19, 2022	15.00K	Grant	—	Sep 15	View
From 4	—	2.21K	$9.03	$19.99K	Jan 07, 2022	2.21K	Grant	—	Jan 05	View
From 4	—	7.50K	—	—	Aug 18, 2021	7.50K	Grant	—	Aug 17	View
From 4	—	1.31K	$13.31	$17.49K	Jan 06, 2021	1.31K	Grant	—	Jan 04	View
From 4	—	7.50K	—	—	Oct 27, 2020	7.50K	Grant	—	Oct 27	View
From 4	—	2.70K	$6.47	$17.49K	Jan 06, 2020	2.70K	Grant	—	Jan 02	View
From 4	—	6.07K	—	—	Jun 05, 2019	6.07K	Grant	—	Jun 05	View
From 4	—	6.07K	—	—	Jun 06, 2018	6.07K	Grant	—	Jun 05	View
From 3	—	—	—	—	Nov 01, 2017	—	—	—	—	View

ORTXorchard therapeutics plc

See Remarks

Updated: Jan 24, 2024VIEW QUOTE

Form Type	Δ Own, %	Traded Shares	Price	Size, $	Filing Date	Own, %	Type	Scheduled	Trade Dates	SEC Filing
From 4	-1.00	2.33M	—	—	Jan 24, 2024	—	Disposition	—	Jan 24	View
From 4	—	—	$0.46	$9.18K	Mar 14, 2023	427.08K	Options	—	Mar 10	View
From 4	—	585.00K	—	—	Mar 03, 2023	585.00K	Grant	—	Mar 01	View
From 4	—	—	$0.46	$9.18K	Feb 13, 2023	427.08K	Options	—	Feb 09	View
From 4	0.38	532.81K	—	—	Oct 06, 2022	1.93M	Acquisition	—	Oct 04	View
From 4	—	375.00K	—	—	Jun 03, 2022	375.00K	Grant	—	Jun 01	View
From 4	0.24	10.00K	$0.75	$7.47K	Apr 04, 2022	52.08K	Purchase	—	Apr 01	View
From 4	—	337.73K	—	—	Feb 03, 2021	337.73K	Grant	—	Feb 01	View
From 4	—	—	$2.44	$24.40K	Feb 01, 2021	468.27K	Options	—	Jan 29	View
From 4	0.28	6.96K	$6.72	-$24.90K	Jan 12, 2021	32.08K	Grant	—	Jan 08 - 11	View
From 4	—	—	$2.44	$24.40K	Jun 15, 2020	461.31K	Options	—	Jun 11	View
From 4	—	150.00K	—	—	Apr 03, 2020	150.00K	Grant	—	Apr 01	View
From 4	—	200.00K	—	—	Jan 06, 2020	200.00K	Grant	—	Jan 02	View
From 3	—	—	—	—	Jan 02, 2020	15.12K	—	—	—	View

amag pharmaceuticals inc.

President & COO Officer

Updated: Feb 27, 2017

Form Type	Δ Own, %	Traded Shares	Price	Size, $	Filing Date	Own, %	Type	Scheduled	Trade Dates	SEC Filing
From 4	0.47	54.00K	—	—	Feb 27, 2017	168.20K	Grant	—	Feb 23	View
From 4	0.44	47.25K	$26.97	-$263.00K	Mar 01, 2016	154.20K	Grant	—	Feb 26 - 01	View
From 4	-0.02	2.36K	$61.71	-$145.82K	Aug 21, 2015	106.95K	Tax	—	Aug 20	View
From 4	-0.09	15.00K	$40.88	-$779.10K	Aug 07, 2015	154.31K	Sale	Scheduled	Aug 05	View
From 4	-0.15	20.00K	$69.47	-$1.39M	Jun 08, 2015	109.31K	Sale	—	Jun 04	View
From 4	-0.03	4.28K	$49.70	-$212.67K	Mar 05, 2015	129.31K	Tax	—	Mar 03	View
From 4	0.31	37.50K	—	—	Feb 27, 2015	158.59K	Grant	—	Feb 26	View
From 4	-0.05	7.05K	$40.49	-$285.29K	Dec 18, 2014	121.09K	Tax	—	Dec 17	View
From 4	0.45	40.00K	—	—	Aug 21, 2014	128.13K	Grant	—	Aug 19	View
From 4	0.48	39.40K	—	—	Feb 28, 2014	121.93K	Grant	—	Feb 27	View
From 4	-0.04	3.27K	$23.23	-$75.87K	Dec 17, 2013	82.53K	Tax	—	Dec 16	View
From 4	2.56	56.30K	—	—	Mar 04, 2013	78.30K	Grant	—	Feb 28	View
From 4	2.50	30.00K	$15.60	-$155.97K	Jan 04, 2013	42.00K	Sell-Options	Scheduled	Jan 03	View
From 4	2.14	15.00K	$15.08	-$75.40K	Dec 04, 2012	22.00K	Sell-Options	Scheduled	Nov 30	View
From 4	1.00	10.00K	—	—	Aug 03, 2012	20.00K	Options	—	Aug 01	View
From 4	0.33	500.00	$15.86	$7.93K	Apr 02, 2012	2.00K	Purchase	Scheduled	Apr 02	View
From 4	0.50	500.00	$15.81	$7.91K	Mar 02, 2012	1.50K	Purchase	Scheduled	Mar 01	View
From 4	1.00	500.00	$16.56	$8.28K	Feb 02, 2012	1.00K	Purchase	Scheduled	Feb 01	View
From 4	—	40.50K	$19.10	$9.55K	Jan 04, 2012	40.50K	Purchase	Scheduled	Jan 03	View
From 4	—	20.00K	—	—	Dec 02, 2011	20.00K	Grant	—	Nov 30	View
From 4	—	80.00K	—	—	Aug 01, 2011	80.00K	Grant	—	Aug 01	View
From 3	—	—	—	—	Aug 01, 2011	—	—	—	—	View

critical therapeutics inc

President & CEO Director

Updated: Aug 22, 2007

Form Type	Δ Own, %	Traded Shares	Price	Size, $	Filing Date	Own, %	Type	Scheduled	Trade Dates	SEC Filing
From 4	0.07	5.00K	$2.12	$10.62K	Aug 22, 2007	72.03K	Purchase	—	Aug 22	View
From 4	0.02	1.50K	$2.24	$3.36K	Jun 14, 2007	67.03K	Grant	—	Jun 13	View
From 4	0.02	1.50K	$2.69	$4.04K	Jun 07, 2007	65.53K	Grant	—	Jun 06	View
From 4	0.03	2.00K	$2.75	$5.50K	Jun 05, 2007	64.03K	Grant	—	Jun 04	View
From 4	0.04	2.15K	$1.59	$3.42K	Jun 04, 2007	62.03K	Acquisition	—	May 31	View
From 4	27.16	540.00K	$40.00	$1.60M	Dec 29, 2006	559.89K	Grant	—	Dec 27	View
From 4	0.10	1.89K	$1.66	$3.13K	Dec 04, 2006	19.89K	Acquisition	—	Nov 30	View
From 4	0.29	4.00K	$3.90	$15.60K	Aug 10, 2006	18.00K	Grant	—	Aug 08	View
From 4	—	430.00K	—	—	Jun 27, 2006	430.00K	Grant	—	Jun 25	View
From 4	—	100.00K	—	—	Jan 04, 2006	100.00K	Grant	—	Jan 03	View
From 4	—	—	$5.63	$5.63K	Nov 02, 2005	213.33K	Options	—	Nov 02	View
From 4	—	—	$5.63	$5.63K	Sep 15, 2005	213.33K	Options	—	Sep 14	View
From 4/A	—	213.33K	$5.63	$56.30K	Apr 26, 2005	213.33K	Options	—	Apr 26 - 28	View
From 4/A	0.20	2.00K	$5.63	$11.26K	Apr 26, 2005	12.00K	Options	—	Jan 25	View
From 4	—	—	$5.63	$11.26K	Jan 25, 2005	321.33K	Options	—	Jan 25	View
From 4/A	—	125.00K	—	—	Sep 14, 2004	125.00K	Grant	—	Sep 08	View
From 4	—	125.00K	—	—	Sep 10, 2004	125.00K	Grant	—	Sep 08	View
From 3	—	—	—	—	May 26, 2004	10.00K	—	—	—	View

esperion therapeutics inc/mi

VP, Finance & CFO Officer

Updated: Feb 12, 2004

Form Type	Δ Own, %	Traded Shares	Price	Size, $	Filing Date	Own, %	Type	Scheduled	Trade Dates	SEC Filing
From 4	-1.00	102.20K	—	—	Feb 12, 2004	—	Disposition	—	Feb 10	View
From 4	-0.32	48.78K	$35.00	-$1.71M	Feb 09, 2004	102.20K	Options	—	Feb 05	View
From 4	—	—	$5.00	$5.00K	Jan 02, 2004	30.95K	Options	—	Dec 30	View
From 4	-0.25	10.00K	$11.70	-$134.02K	Sep 15, 2003	30.76K	Sale	—	Sep 11	View
From 4	-0.66	1.50K	$16.00	-$24.00K	Aug 28, 2003	763.00	Sale	—	Aug 26	View

Benzinga

Benzinga

Net Worth & Trading Activity Over Time

Monthly Trading Pattern

Past Insider Trading and Trends

Holdings & Transactions